Marc L. Molendijk

Marc L. Molendijk

Auto-generated profile, based on publicly available information

Marc L. Molendijk

Institute of Psychology, Department of Clinical Psychology, Leiden University, Leiden, The Netherlands

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Journal of Affective Disorders
Verified
Journal Article
Closed access
MMMarc Molendijk
Marc Molendijk
PMPatricio Molero
Patricio Molero
FSFelipe Ortuño Sánchez-Pedreño
Felipe Ortuño Sánchez-Pedreño
WDWillem Van der Does
Willem Van der Does
MMMiguel Angel Martínez-González
Miguel Angel Martínez-González

21 September 2010 in Molecular Psychiatry
Verified
Journal Article
Open access
MMM L Molendijk
M L Molendijk
BBB A A Bus
B A A Bus
PSPh Spinhoven
Ph Spinhoven
BPB W J H Penninx
B W J H Penninx
GKG Kenis
G Kenis
BEB M Elzinga
B M Elzinga
Recent evidence supports ‘the neurotrophin hypothesis of depression’ in its prediction that brain-derived neurotrophic factor (BDNF) is involved in depression. However, some key questions remain unanswered, including whether abnormalities in BDNF persist beyond the clinical state of depression, whether BDNF levels are related to the clinical features of depression and whether distinct antidepressants affect BDNF levels equally. We addressed these questions and investigated serum BDNF levels in 962 depressed patients, 700 fully remitted persons (6 months) and 382 healthy controls. We found serum BDNF levels to be low in antidepressant-free depressed patients relative to controls (P=0.007) and to depressed patients who were treated with an antidepressant (P=0.001). BDNF levels of fully remitted persons (whether unmedicated or treated with an antidepressant) were comparable to those of controls. Analyzing the sample of antidepressant-free depressed patients showed that BDNF levels were unrelated to the core clinical features of depression such as its severity or first versus a recurrent episode. The antidepressant associated upregulation of serum BDNF in depressed patients was confined to selective serotonin reuptake inhibitors (SSRIs) (P=0.003) and St John's wort (P=0.03). Our results suggest that low serum levels of BDNF are a state abnormality that is evident during depression and normalizes during remission. Increases in serum levels of BDNF during antidepressant treatment appear to be confined to some antidepressants and do not parallel clinical characteristics, such as the severity of depressive symptoms.

2 July 2020 in BJPsych Open
Verified
Journal Article
Open access
PDF file
JHJens-R. Henkelmann
Jens-R. Henkelmann
SBSanne de Best
Sanne de Best
CDCarla Deckers
Carla Deckers
KJKatarina Jensen
Katarina Jensen
MSMona Shahab
Mona Shahab
MMMarc Molendijk
Marc Molendijk
Background: The number of refugees is at its highest since the Second World War and on the rise. Many refugees suffer from anxiety, depression and post-traumatic stress disorder (PTSD), but exact and up-to-date prevalence estimates are not available.Aims: To report the pooled prevalence of anxiety and mood disorders and PTSD in general refugee populations residing in high-income countries and to detect sources of heterogeneity therein.Method: Systematic review with meta-analyses and meta-regression.Results: Systematic searches (final search date 3 August 2019) yielded 66 eligible publications that reported 150 prevalence estimates (total sampleN= 14 882). Prevalence rates were 13 and 42% (95% CI 8–52%) for diagnosed and self-reported anxiety, 30 and 40% (95% CI 23–48%) for diagnosed and self-reported depression, and 29 and 37% (95% CI 22–45%) for diagnosed and self-reported PTSD. These estimates are substantially higher relative to those reported in non-refugee populations over the globe and to populations living in conflict or war settings, both for child/adolescent and adult refugees. Estimates were similar over different home and resettlement areas and independent of length of residence.Conclusions: Our data indicate a challenging and persisting disease burden in refugees due to anxiety, mood disorders and PTSD. Knowing this is relevant for the development of public health policies of host countries. Scalable interventions, tailored for refugees, should become more readily available.

1 December 2015 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
MMMarc L. Molendijk
Marc L. Molendijk
RKRon de Kloet
Ron de Kloet

19 January 2017 in Psychological Medicine
Verified
Journal Article
Closed access
PDF file
MMM. L. Molendijk
M. L. Molendijk
HHH. W. Hoek
H. W. Hoek
TBT. D. Brewerton
T. D. Brewerton
BEB. M. Elzinga
B. M. Elzinga
Background: Meta-analyses have established a high prevalence of childhood maltreatment (CM) in patients with eating disorders (EDs) relative to the general population. Whether the prevalence of CM in EDs is also high relative to that in other mental disorders has not yet been established through meta-analyses nor to what extent CM affects defining features of EDs, such as number of binge/purge episodes or age at onset. Our aim is to provide meta-analyses on the associations between exposure to CM (i.e. emotional, physical and sexual abuse) on the occurrence of all types of EDs and its defining features.Method: Systematic review and meta-analyses. Databases were searched until 4 June 2016.Results: CM prevalence was high in each type of ED (totalN= 13 059, prevalence rates 21–59%) relative to healthy (N= 15 092, prevalence rates 1–35%) and psychiatric (N= 7736, prevalence rates 5–46%) control groups. ED patients reporting CM were more likely to be diagnosed with a co-morbid psychiatric disorder [odds ratios (ORs) range 1.41–2.46,p< 0.05] and to be suicidal (OR 2.07,p< 0.001) relative to ED subjects who were not exposed to CM. ED subjects exposed to CM also reported an earlier age at ED onset [effect size (Hedges’g) = −0.32,p< 0.05], to suffer a more severe form of the illness (g= 0.29,p< 0.05), and to binge-purge (g= 0.31,p< 0.001) more often compared to ED patients who did not report any CM.Conclusion: CM, regardless of type, is associated with the presence of all types of ED and with severity parameters that characterize these illnesses in a dose dependent manner.

1 May 2019 in Behavioural Brain Research
Verified
Journal Article
Open access
MMMarc L. Molendijk
Marc L. Molendijk
RKRon de Kloet
Ron de Kloet
The forced swim test (FST) for rodents does not model despair or helplessness. It also is not a read-out for depression, anxiety, psychomotor retardation or autism, because these are anthropomorphic interpretations of the rodent's acquired immobility. Rather, the transition from swimming to immobility allows to examine the mechanistic underpinning of coping with inescapable stressors. However, in a recent detailed analysis of the FST application over the past 40 years, we noted a dramatic surge in the use of this test to phenotype animals as 'depressed'. As a follow up to that report, we now present an analysis of the use of the FST over the past three years. This literature analysis shows that the popularity of the FST is still increasing and that the majority of researchers qualifies the rodent's floating response as depressive-like behavior. However, over the past few years we also note a trend to interpret immobility rather as the expression of a coping strategy. In view of this result, we have sent a poll to the relevant authors to learn how consistent they are in naming FST behavior. Remarkably, we find a dramatic inverse correlation between their first qualification of acquired immobility as depressive-like behavior towards their current interpretation as coping strategy. In this contribution we have embedded our literature analysis and poll results in an update on the management of coping with inescapable stressors by processing in prefrontal cortical circuitry and glucocorticoid feedback.